Caroline Baumal
CIK 1961100 · Chief Medical Officer · last filed 2026-05-14
Caroline Baumal is a Chief Medical Officer who has filed 11 SEC Form 4 insider transactions across 1 company since 2023. The most recent filing, for APLS, was dated May 14, 2026. Across all open-market trades the lifetime net is −$491.2K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
11
-$491.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. (APLS) Delisted | Chief Medical Officer | 0 | $41.03 | $0 | -$491.2K | 11 | 2026-05-14 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | −137,832 | $0 | EDGAR |
| 2026-05-01 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Gift (G) | −900 | $0 | EDGAR |
| 2026-01-23 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −2,797 | -$60.9K | EDGAR |
| 2026-01-21 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −1,882 | -$37.3K | EDGAR |
| 2026-01-06 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −3,020 | -$77.1K | EDGAR |
| 2025-06-11 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-01-21 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | +37,741 | -$55.5K | EDGAR |
| 2025-01-08 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −2,816 | -$95.2K | EDGAR |
| 2024-01-17 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | +25,445 | $0 | EDGAR |
| 2024-01-05 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −2,751 | -$165.2K | EDGAR |